Dialysis Clinical Trials in Chengdu, Sichuan
4 recruitingChengdu, Sichuan, China
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
End Stage Renal Disease on DialysisHyperphosphatemiaChronic Kidney Disease Requiring Chronic Dialysis
R1 Therapeutics168 enrolled26 locationsNCT06712654
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Not Applicable
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
Peritoneal Dialysis ComplicationSodium-glucose Co-transporter-2 InhibitorsRenal Function Aggravated
Sichuan Academy of Medical Sciences70 enrolled1 locationNCT06398977
Recruiting
Not Applicable
Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients
ExerciseQuality of LifeChronic Kidney Diseases+2 more
Sichuan Academy of Medical Sciences132 enrolled1 locationNCT06368713